Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This article introduces a simple method for expeditious production of giant unilamellar vesicles with encapsulated cytoskeletal proteins. The method proves to be useful for bottom-up reconstitution of cytoskeletal structures in confinement and cytoskeleton-membrane interactions.

Abstract

Giant unilamellar vesicles (GUVs) are frequently used as models of biological membranes and thus are a great tool to study membrane-related cellular processes in vitro. In recent years, encapsulation within GUVs has proven to be a helpful approach for reconstitution experiments in cell biology and related fields. It better mimics confinement conditions inside living cells, as opposed to conventional biochemical reconstitution. Methods for encapsulation inside GUVs are often not easy to implement, and success rates can differ significantly from lab to lab. One technique that has proven to be successful for encapsulating more complex protein systems is called continuous droplet interface crossing encapsulation (cDICE). Here, a cDICE-based method is presented for rapidly encapsulating cytoskeletal proteins in GUVs with high encapsulation efficiency. In this method, first, lipid-monolayer droplets are generated by emulsifying a protein solution of interest in a lipid/oil mixture. After being added into a rotating 3D-printed chamber, these lipid-monolayered droplets then pass through a second lipid monolayer at a water/oil interface inside the chamber to form GUVs that contain the protein system. This method simplifies the overall procedure of encapsulation within GUVs and speeds up the process, and thus allows us to confine and observe the dynamic evolution of network assembly inside lipid bilayer vesicles. This platform is handy for studying the mechanics of cytoskeleton-membrane interactions in confinement.

Introduction

Lipid bilayer compartments are used as model synthetic cells for studying enclosed organic reactions and membrane-based processes or as carrier modules in drug delivery applications1,2. Bottom-up biology with purified components requires minimal experimental systems to explore properties and interactions between biomolecules, such as proteins and lipids3,4. However, with the advancement of the field, there is an increased need for more complex experimental systems that better imitate the conditions in biological cells. Encapsulation in GUVs is a practi....

Protocol

1. Preparation of oil-lipid-mixture

NOTE: The step needs to be performed in a fume hood following all the safety guidelines for handling chloroform.

  1. Take 0.5 mL of chloroform in a 15 mL glass vial. Add 88 µL of 25 mg/mL dioleoyl-phosphocholine (DOPC), 9.3 µL of 50 mg/mL cholesterol, and 5 µL of 1 mg/mL dioleoyl-phosphoethanolamine-lissamine rhodamine B (rhodamine PE) (see Table of Materials) into the 15 ml glass vial.
    NOTE: Th.......

Representative Results

To demonstrate the successful generation of cytoskeletal GUVs using the current protocol, fascin-actin bundle structures in GUVs were reconstituted. Fascin is a short crosslinker of actin filaments which forms stiff parallel-aligned actin bundles and is purified from E. coli as Glutathione-S-Transferase (GST) fusion protein26. 5 µM of actin was first reconstituted, including 0.53 µM of ATTO488 actin in the actin polymerization buffer and 7.5% of the density gradient medium. Upon.......

Discussion

Different methods of generating GUVs have been explored for the creation of synthetic cells However, the complexity of the procedures, extended time to attain encapsulation, restriction of lipid types and molecular composition of the encapsulant, need for non-physiological chemicals to facilitate encapsulation, low GUV yield, and inconsistencies in encapsulation efficiency have continued to challenge researchers in this field. Considering the wide range of potential studies that can be embarked in bottom-up syntheti.......

Acknowledgements

APL acknowledges support by a Humboldt Research Fellowship for Experienced Researchers and from the National Science Foundation (1939310 and 1817909) and National Institutes of Health (R01 EB030031).

....

Materials

NameCompanyCatalog NumberComments
18:1 Liss Rhod PE lipid in chloroformAvanti Polar Lipids810150C
96 Well Optical Btm Pit PolymerBaseThermoFisher Scientific165305
Actin from rabbit skeletal muscleCytoskeletonAKL99-A
ATTO 488-actin from rabbit skeletal muscleHypermol8153-01
Axygen microtubes (200 µL)Fisher Scientific14-222-262for handling ABPs
Black resinFormlabsRS-F2-GPBK-04
Cholesterol (powder)Avanti Polar Lipids700100P
CholoroformSigma Aldrich67-66-3
Clear resinFormlabsRS-F2-GPCL-04
CSU-X1 Confocal Scanner UnitYOKOGAWACSU-X1
Density gradient medium (Optiprep)Sigma-AldrichD1556
DOPC lipid in chloroformAvanti Polar Lipids850375C
FascinhomemadeN/A
F-bufferhomemadeN/A
Fisherbrand microtubes (1.5 mL)Fisher Scientific05-408-129
FS02 SonicatorFischer ScientificFS20
G-bufferhomemadeN/A
GlucoseSigma-Aldrich158968
iXon X3 cameraAndorDU-897E-CS0
Mineral oilAcros Organics8042-47-5
Olympus IX81 Inverted MicroscopeOlympusIX21
Olympus PlanApo N 60x Oil Microscope ObjectiveOlumpus1-U2B933
Silicone oilSigma-Aldrich317667

References

  1. Groaz, A., et al. Engineering spatiotemporal organization and dynamics in synthetic cells. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 13 (3), 1685 (2021).
  2. Diltemiz, S. E., et al. Use of artificial cells as drug car....

Explore More Articles

Giant Unilamellar VesiclesCytoskeleton ReconstitutionIn Vitro ReconstitutionSynthetic Cell ResearchCell free Transcription translationMinimal ProtocellsOil lipid MixtureLipid oil DispersionActin PolymerizationActin Binding Proteins

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved